EFN

Abnormal and malignant growth of cells in prostate gland can lead to Prostate cancer (or Adenocarcinoma). It is the second most common cancer and found only in men. Higher levels of hormone (especially Androgens) can be of high risk and may induce growth of tumor cells. Other factors may include age, hereditary (or genetic), diet, obesity, smoking or infection and inflammation of prostate gland.

Recent guidelines published by American Society of Clinical Oncology and the American Urological Association reveal that common drug, Finasteride, used in male baldness is effective in preventing Prostate cancer. Guidelines also recommend a daily dose of Finasteride for the male above age 55. It is believed that high doses of Finasteride acts by interfering male hormones which fuel the growth of cancerous cell. They also shrink enlarged prostate gland and hence reducing the risk of prostate cancer.

Finasteride and other drugs in the same class have shown side effects like impotency or lower sex drive, but it is always better to evaluate risk is to benefit ratio. Since prostate cancer is seen more common in older men it is advised to consult doctor and health care physician to discuss if Finasteride can be good for them.